SLC5A2 and type 2 diabetes mellitus: To decipher the cellular and molecular mechanism of action of SGLT2 inhibitors, animal models for type 2 diabetes, obesity, and cardiovascular diseases and other animal models of pathological inflammation were used by a number of research groups.